If New York legislators have questions about the efficacy of the 340B Drug Pricing Program, they should look closely at a ...
The American Hospital Association argues new policies from Eli Lilly and Novo Nordisk requiring providers to submit more ...
A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.
Drug companies are at it again. They will not relent in their multiyear campaign to dismantle the 340B Drug Pricing Program. Drug companies are at it again. They will not relent in their multiyear ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results